Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

ABGX

Abgenix (ABGX)

Abgenix (MM)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ABGX

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
30/03/2006	16h00	Business Wire	Amgen and Abgenix Complete Biologics License Application for FDA Approval of Panitumumab	NASDAQ:ABGX	Abgenix (MM)
30/03/2006	01h10	PR Newswire (US)	Abgenix Announces Stockholder Approval of Acquisition by Amgen	NASDAQ:ABGX	Abgenix (MM)
14/02/2006	14h30	PR Newswire (US)	Abgenix to Host Fourth Quarter and Full Year 2005 Conference Call	NASDAQ:ABGX	Abgenix (MM)
05/01/2006	14h30	PR Newswire (US)	Abgenix to Present at JPMorgan 24th Annual Healthcare Conference	NASDAQ:ABGX	Abgenix (MM)
14/12/2005	22h06	PR Newswire (US)	Amgen to Acquire Abgenix for $22.50 Per Share	NASDAQ:ABGX	Abgenix (MM)
09/11/2005	22h01	PR Newswire (US)	Abgenix Appoints Jeffrey H. Knapp as Senior Vice President of Sales and Marketing	NASDAQ:ABGX	Abgenix (MM)
03/11/2005	14h02	PR Newswire (US)	Panitumumab Significantly Improves Progression-Free Survival in Phase 3 Randomized Metastatic Colorectal Cancer Study	NASDAQ:ABGX	Abgenix (MM)
03/11/2005	14h01	Business Wire	Panitumumab Significantly Improves Progression-Free Survival in Phase 3 Randomized Metastatic Colorectal Cancer Study	NASDAQ:ABGX	Abgenix (MM)
03/11/2005	14h00	Business Wire	Media Notification/Webcast Notification - Amgen and Abgenix to Conduct Conference Call and Webcast Regarding Panitumumab Pivotal	NASDAQ:ABGX	Abgenix (MM)
03/11/2005	14h00	PR Newswire (US)	Media Notification/Webcast Notification - Amgen and Abgenix to Conduct Conference Call and Webcast Regarding Panitumumab Pivotal	NASDAQ:ABGX	Abgenix (MM)
25/10/2005	23h00	PR Newswire (US)	Abgenix Announces Third Quarter 2005 Financial Results	NASDAQ:ABGX	Abgenix (MM)
18/10/2005	23h30	PR Newswire (US)	Abgenix to Host Third Quarter 2005 Conference Call	NASDAQ:ABGX	Abgenix (MM)
01/09/2005	23h30	PR Newswire (US)	Abgenix to Webcast Three Upcoming Conference Presentations	NASDAQ:ABGX	Abgenix (MM)
01/08/2005	16h00	PR Newswire (US)	Abgenix and Amgen Announce FDA Grants Panitumumab Fast Track Designation for Metastatic Colorectal Cancer	NASDAQ:ABGX	Abgenix (MM)
26/07/2005	23h00	PR Newswire (US)	Abgenix Announces Second Quarter 2005 Financial Results	NASDAQ:ABGX	Abgenix (MM)
19/07/2005	23h30	PR Newswire (US)	Abgenix to Host Conference Call on Second Quarter 2005 Financial Results	NASDAQ:ABGX	Abgenix (MM)
28/06/2005	20h30	PR Newswire (US)	Abgenix to Consolidate Research Facilities in Preparation for Expanded Development and Commercial Operations	NASDAQ:ABGX	Abgenix (MM)
08/06/2005	23h30	PR Newswire (US)	Abgenix to Present at Goldman Sachs Twenty-Sixth Annual Global Healthcare Conference	NASDAQ:ABGX	Abgenix (MM)
20/05/2005	23h30	PR Newswire (US)	Abgenix to Present at Needham & Company's Fourth Annual Biotechnology Conference	NASDAQ:ABGX	Abgenix (MM)
17/05/2005	15h00	PR Newswire (US)	Further Phase 2 Data Confirm Panitumumab Single-Agent Antitumor Activity in Patients With Metastatic Colorectal Cancer	NASDAQ:ABGX	Abgenix (MM)
12/05/2005	02h30	PR Newswire (US)	Abgenix Appoints Marc Better, Ph.D., as Vice President of Process Sciences	NASDAQ:ABGX	Abgenix (MM)
27/04/2005	01h30	PR Newswire (US)	Phase 3 Clinical Trial Initiated to Evaluate the Use of Panitumumab Therapy For First-Line Treatment of Metastatic Colorectal Ca	NASDAQ:ABGX	Abgenix (MM)
26/04/2005	23h00	PR Newswire (US)	Abgenix Announces First Quarter 2005 Financial Results	NASDAQ:ABGX	Abgenix (MM)
18/04/2005	13h30	PR Newswire (US)	Abgenix to Host Conference Call on First Quarter 2005 Financial Results	NASDAQ:ABGX	Abgenix (MM)
15/04/2005	13h30	PR Newswire (US)	Abgenix Announces Data Presentations for Panitumumab at AACR and ASCO Annual Meetings	NASDAQ:ABGX	Abgenix (MM)
23/03/2005	22h00	PR Newswire (US)	Abgenix to Present at the Smith Barney Citigroup 2005 Healthcare Conference	NASDAQ:ABGX	Abgenix (MM)
18/03/2005	12h00	PR Newswire (US)	Panitumumab Pivotal Trial Completes Patient Enrollment	NASDAQ:ABGX	Abgenix (MM)
17/03/2005	22h53	PR Newswire (US)	Abgenix Files Resale Registration Statement	NASDAQ:ABGX	Abgenix (MM)
14/03/2005	15h01	PR Newswire (US)	Abgenix and Genentech Extend Antibody Technology Licensing Agreement	NASDAQ:ABGX	Abgenix (MM)
04/03/2005	22h00	PR Newswire (US)	Abgenix Appoints Donald R. Joseph as Senior Vice President, General Counsel and Secretary	NASDAQ:ABGX	Abgenix (MM)

Showing the most relevant articles for your search:NASDAQ:ABGX

TD Canadian Bank Dividen...

Hidrovias DO Brasil ON

Deka Iboxx Eur Liquid So...

MSCI WORLD INDEX UCITS ETF

Lyxor Stoxx Europe 600 C...

Worldline SA 0% until 30...

Arizona Metals (QX)

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen